NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer
Status:
Active, not recruiting
Trial end date:
2023-11-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out the effects of chemotherapy followed by less
invasive surgery on patients and their early rectal cancer. The approach of this trial will
be considered a success if at least 65% of participants are able to keep the rectum.